CTVACorteva

$82.90

The financials

Corteva by the numbers

Corteva (CTVA) reported revenue of $6.38B in Q2 2026 (quarter ended June 30, 2026), down 1.2% from the same quarter a year earlier. That came with a gross margin of 57% and net income of $1.16B (18% of revenue). For the full year FY2025, revenue was $17.4B (+2.9% year on year) and net income $1.09B. Its largest product in 2026-Q1 was Corn at $2.37B, 49% of the disclosed total, just ahead of Herbicides at 21%.

Corteva income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$6.38B$6.46B−1.2%
Gross profit$3.66B$3.52B+3.9%
Net income$1.16B$1.31B−12%
Diluted EPS$1.73$1.92−9.9%
Revenue by product, 2026-Q1, as reported to the SEC
ProductRevenueShare
Corn$2.37B49%
Herbicides$1.03B21%
Insecticides$377M7.8%
Fungicides$334M6.9%
Soybean$306M6.3%
Otheroilseeds$245M5.1%
Other$99M2.0%
Biologicals$70M1.4%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Q1 2026Total $4.83B (+93%)
Herbicides grew +19% year on yearBiologicals -17% year on year
  • Corn$2.37BQoQ +305%year on year +15%
  • Herbicides$1.03BQoQ +26%year on year +19%
  • Insecticides$377.0MQoQ -7.8%year on year +12%
  • Fungicides$334.0MQoQ +50%year on year +9.9%
  • Soybean$306.0MQoQ +101%year on year +0.33%
  • Otheroilseeds$245.0MQoQ +74%year on year +9.9%
  • Other$99.0MQoQ +161%year on year -10.0%
  • Biologicals$70.0MQoQ -52%year on year -17%
Segment sum = 98% of reported consolidated revenue · Latest source: 10-Q filed 2026-05-06, SEC EDGAR